Menlo Park, CA, United States of America

Aashish Manglik

This inventor holds 17 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Cancer Therapeutics. Top assignees: Leland Stanford Junior University, Ab Initio Biotherapeutics, Inc., Friedrich-Alexander-Universitat Erlangen-Nürnberg. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aashish Manglik. Retrieved from https://idiyas.com/inventor/aashish-manglik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 7)

% Patents Active = 94.1

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 11)

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 126(Granted Patents)

Company Filing History:

14 out of 5,527

Leland Stanford Junior University

patents

3 out of 3

Ab Initio Biotherapeutics, Inc.

patents

3 out of 118

Friedrich-Alexander-Universitat Erlangen-Nürnberg

patents

4. 3 out of 16,058

University of California

patents

5. 2 out of 1,331

The University of North Carolina at Chapel Hill

Vrije Universiteit Brussel

patents

where one patent can have more than one assignee

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

PD-1 Agents

Opioid Receptor Modulators

Cancer Treatment

G Protein-Coupled Receptors

Transmembrane Receptors

Polypeptide Compositions

Conformational Selectivity

Binding Agents

SIRP-Gamma Polypeptides

Cell Surface Expression

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12780908 - POTENT ANTIGEN-BINDING DOMAINS THAT BIND PATCHED1 FOR ACTIVATION OF THE HEDGEHOG SIGNALING PATHWAY (2026-11-03),

2. 11814419 - High affinity PD-1 agents and methods of use (2023-11-14),

3. 11484525 - Mu opioid receptor modulators (2022-11-01),

4. 11407801 - SIRP-gamma polypeptide compositions and treatment of cancer (2022-08-09),

5. 11352422 - Opioid receptor binding agents and uses thereof (2022-06-07),

6. 11041868 - Compositions comprising G protein-coupled receptors maintained in a conformationally selective manner by a modulator (2021-06-22),

7. 10829771 - Compositions and methods for expressing polypeptides on the surface of cells (2020-11-10),

8. 10800830 - High affinity PD-1 agents and methods of use (2020-10-13),

9. 10780078 - Mu opioid receptor modulators (2020-09-22),

10. 10774125 - SIRP-gamma polypeptide compositions and methods of use (2020-09-15),

11. 10702498 - MU opioid receptor modulators (2020-07-07),

12. 10520516 - Complexes comprising transmembrane receptors and antibodies that bind the receptors in a conformationally selective manner (2019-12-31),

13. 10233241 - Opioid receptor binding agents and uses thereof (2019-03-19),

14. 9880179 - Method for selecting agents that bind to transmembrane receptors in a conformationally selective manner (2018-01-30),

15. 9845345 - SIRP polypeptide compositions and methods of use (2017-12-19),

Title: The Innovative Journey of Aashish Manglik

Introduction: Aashish Manglik is a pioneering inventor based in Menlo Park, California, known for his groundbreaking contributions to the field of innovation and patents.

Latest Patents: Aashish Manglik holds several recent patents in the areas of biotechnology and pharmaceuticals, showcasing his commitment to advancing scientific research and development.

Career Highlights: With a distinguished career in the field of inventing, Aashish Manglik has been recognized for his exceptional work in developing novel solutions that have the potential to revolutionize industries.

Collaborations: Throughout his career, Aashish Manglik has collaborated with leading researchers, scientists, and institutions to further his innovative projects and bring his ideas to fruition.

Conclusion: Aashish Manglik's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the landscape of technological advancements for years to come.

Profile summary based on public USPTO records.